Pharmafile Logo

EY Life Sciences

Our global reach
Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and adaptability critical for success. Our worldwide team of 190,000 industry-focused management consulting, compliance, business development and tax professionals — with deep sector knowledge and technical experience — can help you address these myriad changes and compete effectively in this dynamic environment. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.

Strength and depth in the Life Sciences sector
EY is known for its deep power and Life Sciences sector knowledge, relationships with the industry’s key stakeholders, and strong global capabilities. Clients see us as the most globally connected organization among the Big Four. Whether you are already active in multiple geographies or are planning to expand your business to other countries, we can assemble a multinational team that combines deep industry knowledge, experience resolving the issues you are facing, and savvy local advice.

Our Global Life Sciences Team is committed to delivering industry insight that creates value for you. It connects our Life Sciences professionals worldwide and serves as a hub for sharing industry-focused knowledge to help you succeed in a changing world. We make it our business to understand your business and to keep our advice relevant to your needs. We work with you as you transform your business, helping you anticipate the pitfalls and lock in the results on which your future depends. EY serves all of the Forbes Global 2000 top 10 life sciences companies and audits 26% of the global life sciences companies on the list. In addition, EY audits 30% of revenues of the global life sciences companies on the Forbes Global 2000 list.

This broad and deep exposure means we understand the dynamics of the sector and the underlying drivers of the leading actors and our Global Life Sciences sector team, is dedicated to offering industry insight and coordinating a network of more than 7,500 Life Sciences professionals worldwide who are ready to develop practical approaches to solving your problems.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Company Details

Ernst & Young LLP, 1 More London Place, London, SE1 2AF, United Kingdom

 Latest Content from PMHub 

Havas Lynx celebrates 40 years of impact

Press Releases | May 6, 2026 | Havas Lynx

Starting out in 1986 as a team of two in Manchester’s Northern Quarter, Havas Lynx has much to celebrate, having grown to become an international healthcare communications agency with offices...

Cuttsy+Cuttsy welcomes three new experts to the team

Cuttsy+Cuttsy is happy to be welcoming three new people to the team this month.

Durbin PLC becomes Uniphar, bolstering medicine access amidst growing healthcare demands

Press Releases | May 6, 2026 | Uniphar

Against the backdrop of widespread medicine shortages, Durbin PLC’s rebrand to Uniphar and integration into Uniphar | Global Sourcing represents a strategic move to address industry-wide challenges, expanding its sourcing...

Inizio Unveils Next-Generation Hub Services at Asembia 2026, Setting a New Standard in Patient Access

Press Releases | May 5, 2026 | Inizio

Integrated capabilities combining advanced analytics, pharmacy, and specialized talent to improve access, affordability, and adherence

The silent drop-off: How disengagement shows up in everyday behaviour

Press Releases | May 5, 2026 | Mednet

In healthcare, disengagement rarely announces itself. It doesn’t always appear as refusal or a clear decision to stop treatment. More often, it shows up quietly, in what is delayed, avoided...

Keep the Beat Going: Education and Impact at the European Society of Cardiology Heart Failure Congress 2026

Did you know? Over 320,000 learners have engaged with heart failure content on Medscape. With such an enthusiastic audience for our education, we’re thrilled to be joining cardiology professionals from...

The Power of Partnership in Respiratory Care

In the fast-paced world of modern medicine, success is often measured by the volume of tests and the precision of data. However, as Dr. Doreen Addrizzo-Harris and Dr. Martina Flammer...

Why clinical innovation doesn’t translate into real-life outcomes

Press Releases | April 30, 2026 | Mednet

We’ve made extraordinary progress in healthcare. However, outcomes depend on whether people can make treatment work in their lives.

Strategies to enhance the provider and patient EAP experience

Expanded access programs (EAPs) play a multifaceted role in the drug development life cycle, serving as a critical bridge between clinical trials and commercial availability.